Which procedure is indicated for patients with Hodgkin's lymphoma?

In patients with Hodgkin's lymphoma, splenectomy may be indicated in certain clinical situations, particularly when the spleen is enlarged (splenomegaly) or involved in the disease process. The spleen plays a crucial role in the body's immune response, and its involvement in Hodgkin's lymphoma can lead to complications or a higher tumor burden. By removing the spleen, there can be a reduction in the amount of lymphoma present, potentially leading to better management outcomes.

Additionally, splenectomy can help relieve symptoms such as pain or discomfort associated with splenomegaly. In some treatment protocols, especially in earlier stages of the disease, the removal of the spleen is considered as part of a combination therapy that may include chemotherapy and radiation.

In contrast, the other procedures listed do not have a direct indication for the treatment of Hodgkin's lymphoma. Laparoscopic cholecystectomy addresses gallbladder disease, bone marrow biopsy is primarily used for diagnosing hematological malignancies and assessing bone marrow involvement, and thoracotomy is typically related to surgical access for thoracic conditions rather than specific treatment for lymphoma. Thus, the context of Hodgkin's lymphoma and the role of splenectomy in its management make this the appropriate